Agouron Pharmaceuticals (AGPH) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Agouron Pharmaceuticals (AGPH)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: M. Alexander who wrote (5556)	10/20/1998 8:47:00 PM
From: per strandberg	Read Replies (1) of 6136

M A, with your broker experience, can you tell what will happen with shorted shares when/if AGPH spins off the oncology company: Will the new oncology shares belong to the registered shareholder or the holder of shorted, borrowed shares? As far as I know, any dividend is a loss for the shorter. When a short position is covered, is it then necessary to buy both types of shares in correct proportions? I can't make out if the spin off is good/neutral/bad for the shorts? ps

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next